ClinicalTrials.Veeva

Menu

Copeptin in Aortic Valve Replacement (CARE)

G

German Heart Center Munich

Status

Completed

Conditions

Copeptin in Patients Undergoing Aortic Valve Replacement

Study type

Observational

Funder types

Other

Identifiers

NCT01648647
GE DHM-AN-OR-2012/01

Details and patient eligibility

About

Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing surgical aortic valve replacment
  • Patients undergoing transcatheter aortic valve replacment

Exclusion criteria

  • denial by patient

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems